Concepedia

MG Murphy

MM

Statistics

Publications

4

Citations

156

H-Index

4

Active since

2010

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

KU Leuven

MSD (Belgium)

United States Military Academy

MSD (UK) Limited (United Kingdom)

MG Murphy is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, psychopharmacology, and gabaergic signaling.

Publications per year

2010–2013

4

Publications

4

Preclinical and clinical pharmacology of TPA023B, a GABA <sub>A</sub> receptor α2/α3 subtype-selective partial agonist

DJ Hallett, Spencer J. Tye, Christine Ryan et al. · Journal of Psychopharmacology · 2010 · 63 citations · Full text

, , +17

MRK-409 (MK-0343), a GABA <sub>A</sub> receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans

L O N D O N Gower Street, G. D. Dawson, Spencer J. Tye et al. · Journal of Psychopharmacology · 2010 · 60 citations · Full text

, , +16

The effects of TPA023, a GABA <sub>A</sub> α <sub>2,3</sub> subtype-selective partial agonist, on essential tremor in comparison to alcohol

SL de Haas, RWM Zoethout, Kristien Van Dyck et al. · Journal of Psychopharmacology · 2011 · 20 citations

, , +16

Lack of hemodynamic interaction between CGRP-receptor antagonist telcagepant (MK-0974) and sumatriptan: Results from a randomized study in patients with migraine

Marleen Depré, Caitlin S. MacLeod, John Palcza et al. · Cephalalgia · 2013 · 13 citations · Full text

, , +15

1–4 of 4